Display options
Share it on

Neuropsychiatr Dis Treat. 2007 Dec;3(6):705-9. doi: 10.2147/ndt.s518.

Neuropsychological assessment, neuroimaging, and neuropsychiatric evaluation in pediatric and adult patients with sickle cell disease (SCD).

Neuropsychiatric disease and treatment

Christopher L Edwards, Renee Dunn Raynor, Miriam Feliu, Camela McDougald, Stephanie Johnson, Donald Schmechel, Mary Wood, Gary G Bennett, Patrick Saurona, Melanie Bonner, Chante' Wellington, Laura M DeCastro, Elaine Whitworth, Mary Abrams, Patrick Logue, Lekisha Edwards, Salutario Martinez, Keith E Whitfield

Affiliations

  1. Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC, USA. [email protected]

PMID: 19300604 PMCID: PMC2656311 DOI: 10.2147/ndt.s518

Abstract

Traditionally, neuropsychological deficits due to Sickle Cell Disease (SCD) have been understudied in adults. We have begun to suspect, however, that symptomatic and asymptomatic Cerebrovascular Events (CVE) may account for an alarming number of deficits in this population. In the current brief review, we critically evaluated the pediatric and adult literatures on the neurocognitive effects of SCD. We highlighted the studies that have been published on this topic and posit that early detection of CVE via neurocognitive testing, neuropsychiatric evaluations, and neuroimaging may significantly reduce adult cognitive and functional morbidities.

Keywords: cerebral vascular event; neuroimaging; neuropsychological assessment; sickle cell disease

References

  1. J Dev Behav Pediatr. 2004 Oct;25(5):303-10 - PubMed
  2. Hematology Am Soc Hematol Educ Program. 2004;:14-34 - PubMed
  3. J Pediatr Psychol. 2000 Jul-Aug;25(5):287-99 - PubMed
  4. Br J Haematol. 2006 Jan;132(1):99-107 - PubMed
  5. J Natl Med Assoc. 2006 Mar;98(3):420-8 - PubMed
  6. J Pediatr. 1998 Jun;132(6):994-8 - PubMed
  7. Ann Neurol. 2006 Apr;59(4):662-72 - PubMed
  8. J Child Neurol. 2005 Feb;20(2):102-7 - PubMed
  9. Brain. 2006 Aug;129(Pt 8):2177-88 - PubMed
  10. Neurology. 1998 Jun;50(6):1678-82 - PubMed
  11. J Magn Reson Imaging. 1998 May-Jun;8(3):535-43 - PubMed
  12. J Learn Disabil. 1993 Jan;26(1):33-45 - PubMed
  13. J Natl Med Assoc. 2005 Dec;97(12):1622-9 - PubMed
  14. Neuropsychol Rev. 2001 Dec;11(4):179-96 - PubMed
  15. Arch Phys Med Rehabil. 1991 Jun;72(7):498-502 - PubMed
  16. J Child Neurol. 2002 Feb;17(2):111-6 - PubMed
  17. Dev Sci. 2006 Jul;9(4):379-87 - PubMed
  18. Ment Retard Dev Disabil Res Rev. 2006;12(3):200-7 - PubMed
  19. J Pediatr Hematol Oncol. 2001 Feb;23(2):79-83 - PubMed
  20. J Pediatr Psychol. 2002 Apr-May;27(3):235-44 - PubMed
  21. J Child Neurol. 2002 Dec;17(12):891-5 - PubMed
  22. Ann Neurol. 2003 Nov;54(5):564-72 - PubMed
  23. Clin Neuropsychol. 2003 Feb;17(1):34-44 - PubMed
  24. Pediatr Blood Cancer. 2005 May;44(5):500-7 - PubMed
  25. Am J Pediatr Hematol Oncol. 1991 Spring;13(1):14-20 - PubMed
  26. Radiology. 2003 Jul;228(1):208-15 - PubMed
  27. Pediatrics. 1996 Jun;97(6 Pt 1):864-70 - PubMed
  28. J Pediatr Psychol. 2004 Mar;29(2):83-92 - PubMed
  29. J Pediatr Psychol. 2002 Dec;27(8):739-48 - PubMed
  30. J Child Neurol. 2000 May;15(5):333-43 - PubMed
  31. AJNR Am J Neuroradiol. 2003 Mar;24(3):382-9 - PubMed
  32. AJNR Am J Neuroradiol. 2005 Mar;26(3):455-62 - PubMed
  33. J Pediatr Psychol. 2004 Dec;29(8):627-33 - PubMed
  34. Ann Neurol. 1999 Mar;45(3):279-86 - PubMed
  35. J Pediatr Hematol Oncol. 2000 Jul-Aug;22(4):335-9 - PubMed
  36. Radiology. 2003 Jul;228(1):216-25 - PubMed
  37. J Pediatr Psychol. 2000 Oct-Nov;25(7):503-13 - PubMed
  38. Cogn Behav Neurol. 2005 Mar;18(1):5-17 - PubMed
  39. Int J Behav Med. 2005;12(3):171-9 - PubMed
  40. Blood. 1998 Jan 1;91(1):288-94 - PubMed
  41. East Afr Med J. 1989 Oct;66(10):653-7 - PubMed
  42. J Dev Behav Pediatr. 1988 Aug;9(4):213-20 - PubMed

Publication Types